- $135.43m
- $618.64m
- $553.24m
- 30
- 78
- 42
- 48
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 514 | 383 | 567 | 555 | 553 |
Cost of Revenue | |||||
Gross Profit | 418 | 290 | 405 | 403 | 400 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 917 | 812 | 647 | 1,359 | 862 |
Operating Profit | -403 | -429 | -79.9 | -804 | -309 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -838 | 2,717 | -105 | -831 | -365 |
Provision for Income Taxes | |||||
Net Income After Taxes | -849 | 2,670 | -96.1 | -790 | -349 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -849 | 2,670 | -96.1 | -725 | -349 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -849 | 2,670 | -96.1 | -725 | -349 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -82.8 | 458 | -11.5 | -43.5 | -25.4 |